Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment

Neurotoxicity Research

Volumn 11, Issue 1, 2007, Pages 41-50

  Kostrzewa, Richard M ^a   Huang, Nuo Yu ^b   Kostrzewa, John P ^a   Nowak, Przemyslaw ^c   Brus, Ryszard ^c  

^a East Tennessee State University   (United States)

^b DOV Pharmaceutical Inc   (United States)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

5 HT2 receptor antagonists; 6 Hydroxydopamine; Dopamine receptor supersensitivity; Serotonin receptor supersensitivity; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; IODODIMETHOXYPHENYLAMINOPROPANE; KETANSERIN; LEVODOPA; MESULERGINE; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; OXIDOPAMINE; PHENOXYBENZAMINE; PINDOLOL; PROPRANOLOL; RISPERIDONE; RITANSERIN; SARIZOTAN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SPIPERONE; SULPIRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DOPAMINE; SEROTONIN ANTAGONIST;

ARTICLE; DISEASE ASSOCIATION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; INCIDENCE; LONG TERM CARE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OROFACIAL DYSKINESIA; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; RISK REDUCTION; SEROTONINERGIC SYSTEM; TARDIVE DYSKINESIA; ANIMAL; DRUG EFFECT; DYSKINESIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAT; REVIEW;

ANIMALIA; RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; DYSKINESIA, DRUG-INDUCED; HUMANS; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, DOPAMINE D1; SEROTONIN ANTAGONISTS;

EID: 34249667700     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033481     Document Type: Article

References (51)

1. Arnt J, J Hyttel and J Perregard (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist, quinpirole, facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133, 137-145.
2. Berger TW, S Kaul, EM Stricker and MJ Zigmond (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res. 366, 354-358.
3. Breese GR, AA Baumeister, TJ McCown, SG Emerick, GD Frye, K Crotty and RA Mueller (1984) Behavioural differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231, 343-354.
4. 1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 235, 287-295.
5. 2-dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240, 167-176.
6. 2 receptor priming and cognitive deficits produced by neonatal quinpirole treatment. Soc. Neurosci. Abstr. #884.7.
7. Brus R, RM Kostrzewa, KW Perry and RW Fuller (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J. Pharmacol. Exp. Ther. 268, 231-237.
8. Casey DE (1987T Tardive dyskinesia, In: Psychopharmacology: the Third Generation of Progress (Meltzer HY, Ed.) (Raven Press: New York), pp 1411-1419.
9. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9, 125-133.
10. 1 -dopamine receptor sensitization in neonatal-6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Res. 512, 284-290.
11. 1 dopamine receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536, 287-296.
12. Doucet G, L Descarries and S Garcia (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19, 427-445.
13. Duncan GE, HE Criswell, TJ McCown, IA Paul, RA Mueller and GR Breese (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 243, 1027-1034.
14. El Mansari MF Radja, A Ferron, TA Reader, E Molina-Holgado and L Descarries (1994) Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur. J. Pharmacol. 261, 171-178.
15. Ellison GD and RE See (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology (Berl.) 98, 564-566.
16. Fernandes Xavier FG, G Doucet, M Geffard and L Descarries (1994) Dopamine neoinnervation in the substantia nigra and hyperinnervation in the interpeduncular nucleus of adult rat following neonatal cerebroventricular administration of 6-hydroxydopamine. Neuroscience 59, 77-87.
17. Gong L and RM Kostrzewa (1992) Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 41, 621-623.
18. Gong L, RM Kostrzewa, RW Fuller and KW Perry (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmacol. Exp. Ther. 261, 1000-1007.
19. 1 receptors in neonatal 6-OHDA-lesioned rats. Dev. Brain Res. 76, 59-65.
20. Gong L, RM Kostrzewa, KW Perry and RW Fuller (1993b) Dose-related effects of a neonatal 6-OHDA lesion on SKF-38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76, 233-238.
21. 1 receptor mRNA levels: Absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J. Neurochem. 63, 1282-1290.
22. Gunne LM, SE Bachus and K Gale (1988) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl.) 77, 134-139.
23. Huang N-Y and RM Kostrzewa (1994) Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 253, 163-166.
24. Huang N-Y, RM Kostrzewa, C Li, KW Perry and RW Fuller (1997) Increased spontaneous oral dyskinesias persist in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: Absence of an association with the B max for [3 H]raclopride binding to neostriatal homogenates. J. Pharmacol. Exp. Ther. 280, 268-276.
25. Jeste DV and MP Caligiuri (1993) Tardive dyskinesia. Schizophr. Bull. 19, 303-315.
26. Koshikawa N, S Aoki, M Tomiyama, Y Maruyama and M Kobayashi (1987) Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats. Eur. J. Pharmacol. 133, 119-125.
27. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19, 1-17.
28. 1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol. Biochem. Behav. 39, 677-682.
29. Kostrzewa RM and AHamdi (1991) Potentiation of spiperoneinduced oral activity in rats after neonatal 6-hydroxydopamine. Pharmacol. Biochem. Behav. 38, 215-218.
30. Kostrzewa RM, R Brus, KW Perry and RW Fuller (1993) Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain. Res. 76, 87-93.
31. Kostrzewa RM, TA Reader and L Descarries (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J. Neurochem. 70, 889-898.
32. 2 receptor antagonists on oral activity in rats. Pharmacol. Biochem. Behav. 34, 43-48.
33. Luthman J, B Botioli, T Tustsumi, A Verhofstad and G Jonsson (1987) Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19, 269-274.
34. 2-agonist RU 24213 in young compared with aged rat. Br. J. Pharmacol. 95, 335-342.
35. Moy SS, A Fernandez, Y Qian, DL Rotella, RM Kostrzewa and GR Breese (2004) Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss. Pharmacol. Biochem. Behav. 78, 47-56.
36. Mrini A, J-P Soucy, F Lafaille, P Lemoine and L Descarries (1995) Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons. Brain Res. 669, 303-308.
37. Murray AM and JL Waddington (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: Two directions of D-1:D-2 interaction. Eur. J. Pharmacol. 160, 377-387.
38. Plech A, R Brus, JH Kalbfleisch and RM Kostrzewa (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology (Berl.) 119, 466-473.
39. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience 57, 635-648.
40. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study. Brain Res. 606, 273-285.
41. 1 stimulation. Life Sci. 33, 2479-2482.
42. 2 dopamine receptor function and the emergence of repetitive jaw movements. A dv. Exp. Med. Biol. 235, 159-169.
43. 2 dopamine receptor function and the emergence of repetitive jaw movements. Adv. Exp. Med. Biol. 235, 159-167.
44. 4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 273-279. Epub 2005 Oct 17.
45. Rupniak NMJ, P Jenner and CD Marsden (1985) Pharmacological characterization of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology (Berlin) 85, 71-79.
46. Snyder AM, MJ Zigmond and RD Lund (1986) Sprouting of serotonergic afferents into striatum after dopamine depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J. Comp. Neurol. 245, 274-281.
47. Stachowiak MK, JP Bruno, AM Snyder, EM Stricker and MJ Zigmond (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291, 164-167.
48. Towle AC, HE Criswell, EH Maynard, JM Lauder, RH Joh and RA Mueller and GR Breese (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study. Pharmacol. Biochem. Behav. 34, 367-374.
49. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berl.) 101, 431-447.
50. Waddington JL, AJ Cross, SJ Gamble and RC Bourne (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220, 530-532.
51. Waddington JL, AM Murray, E O'Callaghan and C Larkin (1989) Orofacial dyskinesia: D-1/D-2 dopamine receptors in rodents, and familial/ obstetric correlates of tardive dyskinesia in schizophrenia, In: Neural Mechanisms in Disorders of Movement (AR Crossman and MA Sambrook, Eds.) (Libbey: London), pp 359-366.